These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 12775571)

  • 21. Combined therapy with direct and indirect angiogenesis inhibition results in enhanced antiangiogenic and antitumor effects.
    Abdollahi A; Lipson KE; Sckell A; Zieher H; Klenke F; Poerschke D; Roth A; Han X; Krix M; Bischof M; Hahnfeldt P; Grone HJ; Debus J; Hlatky L; Huber PE
    Cancer Res; 2003 Dec; 63(24):8890-8. PubMed ID: 14695206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiogenesis and apoptosis.
    Folkman J
    Semin Cancer Biol; 2003 Apr; 13(2):159-67. PubMed ID: 12654259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies.
    Eberhard A; Kahlert S; Goede V; Hemmerlein B; Plate KH; Augustin HG
    Cancer Res; 2000 Mar; 60(5):1388-93. PubMed ID: 10728704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiogenesis: new targets for the development of anticancer chemotherapies.
    Gourley M; Williamson JS
    Curr Pharm Des; 2000 Mar; 6(4):417-39. PubMed ID: 10788590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathophysiology of tumor neovascularization.
    Furuya M; Nishiyama M; Kasuya Y; Kimura S; Ishikura H
    Vasc Health Risk Manag; 2005; 1(4):277-90. PubMed ID: 17315600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating endothelial cells as biomarkers for angiogenesis in tumor progression.
    Martin-Padura I; Bertolini F
    Front Biosci (Schol Ed); 2009 Jun; 1(1):304-18. PubMed ID: 19482704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular progenitors derived from murine bone marrow stromal cells are regulated by fibroblast growth factor and are avidly recruited by vascularizing tumors.
    Annabi B; Naud E; Lee YT; Eliopoulos N; Galipeau J
    J Cell Biochem; 2004 Apr; 91(6):1146-58. PubMed ID: 15048870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence from a leukemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells.
    Gunsilius E
    Adv Exp Med Biol; 2003; 522():17-24. PubMed ID: 12674207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vessel pruning or healing: endothelial metabolism as a novel target?
    Cantelmo AR; Pircher A; Kalucka J; Carmeliet P
    Expert Opin Ther Targets; 2017 Mar; 21(3):239-247. PubMed ID: 28081641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis.
    Hicklin DJ; Ellis LM
    J Clin Oncol; 2005 Feb; 23(5):1011-27. PubMed ID: 15585754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiangiogenic and Antitumor Activities of Aflibercept, a Soluble VEGF Receptor-1 and -2, in a Mouse Model of Hepatocellular Carcinoma.
    Torimura T; Iwamoto H; Nakamura T; Abe M; Ikezono Y; Wada F; Sakaue T; Masuda H; Hashimoto O; Koga H; Ueno T; Yano H
    Neoplasia; 2016 Jul; 18(7):413-24. PubMed ID: 27435924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing the in vivo efficacy of biologic antiangiogenic therapies.
    Wilson PM; LaBonte MJ; Lenz HJ
    Cancer Chemother Pharmacol; 2013 Jan; 71(1):1-12. PubMed ID: 23053262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Ape-1/Ref-1 redox antagonist E3330 inhibits the growth of tumor endothelium and endothelial progenitor cells: therapeutic implications in tumor angiogenesis.
    Zou GM; Karikari C; Kabe Y; Handa H; Anders RA; Maitra A
    J Cell Physiol; 2009 Apr; 219(1):209-18. PubMed ID: 19097035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelial Progenitors in the Tumor Microenvironment.
    Testa U; Pelosi E; Castelli G
    Adv Exp Med Biol; 2020; 1263():85-115. PubMed ID: 32588325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiangiogenic strategies and agents in clinical trials.
    Rosen L
    Oncologist; 2000; 5 Suppl 1():20-7. PubMed ID: 10804087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Consequences of angiogenesis for tumor progression, metastasis and cancer therapy.
    Rak JW; St Croix BD; Kerbel RS
    Anticancer Drugs; 1995 Feb; 6(1):3-18. PubMed ID: 7538829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heparin derivatives as angiogenesis inhibitors.
    Presta M; Leali D; Stabile H; Ronca R; Camozzi M; Coco L; Moroni E; Liekens S; Rusnati M
    Curr Pharm Des; 2003; 9(7):553-66. PubMed ID: 12570803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiangiogenic therapy in malignant glioma: promise and challenge.
    Sathornsumetee S; Rich JN
    Curr Pharm Des; 2007; 13(35):3545-58. PubMed ID: 18220791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Epigenetic Profile of Tumor Endothelial Cells. Effects of Combined Therapy with Antiangiogenic and Epigenetic Drugs on Cancer Progression.
    Ciesielski O; Biesiekierska M; Panthu B; Vialichka V; Pirola L; Balcerczyk A
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32283668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.